跳至主要内容
临床试验/IRCT20190624043993N2
IRCT20190624043993N2尚未招募3 期

Evaluation effects of the standard regimen along with ivermectin on treatment of corona virus type 2 pneumonia

Kermanshah University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Definite (clinical and positive PCR) Covid-19 disease
  • Less than 48 hours have passed since the onset of symptoms

排除标准

  • Underlying liver disease/hepatitis
  • Underlying hematological disorders
  • Seizures and encephalopathy
  • Known allergies to ivermectin
  • Pregnancy/lactation
  • Patients who themselves or their legal guardians are reluctant to participate or continue clinical trials

研究者

相似试验